Programme of Excellence Course for Oncology Pharmacy.

Sandton Johannesburg 2023.
Discovery Head Office, 1 Discovery Place, Sandhurst, Sandton,2196 – Opposite Sandton City

Wednesday 10 May 

08.00 – 08.15

Johan Labuschagne (SASOPh Chair) Carien vd Merwe (SASOPh Board):

  Opening / Introduction

08.15 – 09.15

Carien van der Merwe:

Aseptic Technique, Facilities, Room design and HVAC

(**1.C.1)

09.15 – 10.15

Teresa Smit:

  Clinical Trials in Oncology

(**2.B)

10.15 – 10.45

Coffee Break

10.45 – 11.30

 Klaus Meier (ESOP Chair):

Welcome and Medication use Process: quality management

 (**1.A.3)

11.30 – 12.30

 Klaus Meier:

Personal Protective Equipment (PPE) and Spill Kits

 (**1.C.3 / 1.C.4)

12.30 – 13:30

Lunch

13.30 – 15.30

 Klaus Meier:

Devices, Clean working and Waste Disposal

 (**1.D.1 / 1.C.2 / 1.C.5)

15.30 – 16.00

 Coffee Break

16.00 – 17.30

 Dr Christophe Bardin

Prescription check and Methods of Dose Calculation

(**1.C.6 / 1.C.7)

17.30 – 18.30

 Klaus Meier:

The risk of working with cytotoxic drugs and monitoring methods in occupational health EEP

(**1.F.1/ 1.F.2)

11.30 – 12.30

 Klaus Meier:

Personal Protective Equipment (PPE) and Spill Kits

 (**1.C.3 / 1.C.4)

Thursday 11 May 2023 

08.30 – 09.00

 Dr Christophe Bardin

Pharmaceutical Intervention in Emergency Oncology

(**2.J)

09.00 – 10.00

 Dr Christophe Bardin

Interactions of Anticancer Drugs (including CAM)

(**3.G)

10.00 – 10.30

Coffee Break

10.30 – 11.30

Mina Kovacevic:

Patient Counselling

(**3.J.1)

11.30 – 12.30

Mina Kovacevic:

Psycho-Oncology

(**3.K)

12.30 – 13:30

Lunch

13.30 – 15.00

Prof. Alain Astier:

Introducing Biologics in cancer

 (**4.A.3)

15.00 – 15.30

Mina Kovacevic:

Concerns regarding Biosimilars and Biosimilar economics

(**4.F.4/ 4.F.6)

15.30 – 16.00

 Coffee Break

16.00 – 16.45

 Salma Ismail: 

Regulatory aspects of biosimilars

(**4.D.1)

16.45 – 17.45

 Dr Christophe Bardin:

Substitution/ Interchangeability/Switching/ Extrapolation between clinical indication

(**4.D.2/ 4.D.5)

17.45 – 18.45

Prof. Alain Astier

Physiochemical stability of anticancer drugs EEP

[**2.D]

Social Function

Friday 12 May 2023

08.30 – 10.00

Klaus Meier:

Oral Chemotherapy EEP

[**2.C]

10.00 -10.30

Tegan Bilse/Razeeya Khan:

ADR reporting Med Safety Classification of ADRs

EEP [2.F]

10.30 – 11.00

 Coffee Break

11.00 – 12.00

Dr Christophe Bardin:

 Side Effects of Anticancer Drugs EEP

 [**3.H]

12.00 – 12.30

Mina Kovacevic:

 Patient education and counselling on biosimilars

(**4.D.3)

12.30 – 13:30

Lunch

13.30 – 14.30

Dr Smitha Rachel Abraham:

Gynaecological cancers EEP

[**3.L.8]

14.30 -16.00

 Prof. Georgia Demetriou:

 Breast Cancer

 (**3.L.2)

16.00 – 16.30

 Coffee Break

16.30 – 17.30

 Prof. Georgia Demetriou:

Prof Lydia: Dreosti Head/ Neck Cancers

  (**3.L.6)

17.30 – 18.30

Dr Devan Moodley:

 Digestive Cancers 

(**3.L.1)

Saturday 13 May 2023

08.30 – 9.30 

(Dr Dino Chetty tbc):

Radiology in Oncology EEP

[**3.D]

09..30 – 10.00

 Coffee Break

10.00 – 12.00 

Prof Janet Poole:

Treatment of Paediatric Oncology Patients 

(**3.M)

 12.00 – 13.00 

Prof Bernado Rapoport: 

Urological Cancers (Prostate Cancer) 

(**3.L.3)

13.00 – 14.00

Lunch

14.00 – 16.00

 Dr Philippa Ashmore: 

Haematological malignancies 

(**3.L.5)

16.00 – 16.30

 Coffee Break

16.30 – 18.00

Dr Justin du Toit: 

Immunotherapy: pharmacology and clinical use (EEP)

Sunday 14 May 2023

08.00 – 09.30

Prof Paul Ruff: 

Pharmacology of Cancer Chemotherapy (Different classes of drugs) (EEP) 

[**1.B.1]

09.30-10.00 

Mina Kovacevic: 

ATMPS – the future of cancer treatment (EEP)

10.00 – 10.30

Coffee Break

10.30 – 11.30 

Prof Moosa Patel: 

HIV and related cancers (Kaposi Sarcoma) (EEP)

11.30-12.30 

Dr Gregory Landers: 

Lung Cancer 

(**3.L.7)

12.30 – 13:30

Lunch

13.00 – 14.00 

Dr Jason Naicker: 

Melanoma and non-melanoma skin cancers 

(**3.L.4)

14.00 – 15.00 

Dr David Britain: 

Stem Cell Transplantation and CAR-T therapy – (EEP)

15.00 – 15.30 

Klaus Meier: 

Closing


*EEP : Extra ExCOP Program
**EUSOP CODE